Scientists urge FDA to rescind approval of test for opioid addiction risk
The test is aimed at patients who may be prescribed opioids before surgeries. SOLVD Health and the FDA have stressed that the test doesn’t predict if someone will develop an opioid addiction but instead shows if someone is at an “elevated” genetic risk. They say doctors should use the test as part of a comprehensive evaluation of a patient’s risk.